- Home
- VCEL vs BPOPM Comparison
VCEL vs BPOPM Comparison
Compare VCEL & BPOPM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCEL
- BPOPM
- Stock Information
- Founded
- VCEL 1989
- BPOPM N/A
- Country
- VCEL United States
- BPOPM United States
- Employees
- VCEL N/A
- BPOPM N/A
- Industry
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- BPOPM Major Banks
- Sector
- VCEL Health Care
- BPOPM Finance
- Exchange
- VCEL Nasdaq
- BPOPM Nasdaq
- Market Cap
- VCEL 2.1B
- BPOPM N/A
- IPO Year
- VCEL 1997
- BPOPM N/A
- Fundamental
- Price
- VCEL $30.02
- BPOPM $25.17
- Analyst Decision
- VCEL Strong Buy
- BPOPM
- Analyst Count
- VCEL 6
- BPOPM 0
- Target Price
- VCEL $60.60
- BPOPM N/A
- AVG Volume (30 Days)
- VCEL 811.4K
- BPOPM N/A
- Earning Date
- VCEL 11-06-2025
- BPOPM N/A
- Dividend Yield
- VCEL N/A
- BPOPM N/A
- EPS Growth
- VCEL 2045.40
- BPOPM N/A
- EPS
- VCEL 0.13
- BPOPM N/A
- Revenue
- VCEL $249,119,000.00
- BPOPM N/A
- Revenue This Year
- VCEL $18.35
- BPOPM N/A
- Revenue Next Year
- VCEL $22.47
- BPOPM N/A
- P/E Ratio
- VCEL $224.93
- BPOPM N/A
- Revenue Growth
- VCEL 16.13
- BPOPM N/A
- 52 Week Low
- VCEL $29.94
- BPOPM N/A
- 52 Week High
- VCEL $63.00
- BPOPM N/A
- Technical
- Relative Strength Index (RSI)
- VCEL 35.84
- BPOPM 55.95
- Support Level
- VCEL $30.26
- BPOPM $25.01
- Resistance Level
- VCEL $33.25
- BPOPM $25.27
- Average True Range (ATR)
- VCEL 1.67
- BPOPM 0.05
- MACD
- VCEL -0.21
- BPOPM 0.01
- Stochastic Oscillator
- VCEL 1.31
- BPOPM 72.97
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
About BPOPM Popular Inc. Popular Capital Trust II - 6.125% Cumulative Monthly Income Trust Preferred Securities
Popular Capital Trust II is a statutory trust. It is engaged in issuing capital securities.